Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: Anxiety, disability, fatigue and depression

Journal of Neuroimmunology

Volumn 293, Issue , 2016, Pages 54-58

  Shi, Ziyan ^a   Chen, Hongxi ^a   Lian, Zhiyun ^a   Liu, Ju ^a   Feng, Huiru ^a   Zhou, Hongyu ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Anxiety; Depression; Fatigue; Neuromyelitis optica; Quality of life

Indexed keywords

AZATHIOPRINE; MYCOPHENOLATE MOFETIL;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL FEATURE; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; FACTORIAL ANALYSIS; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH COMPOSITE SCORE; MYELOOPTIC NEUROPATHY; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SLEEP DISORDER; ADOLESCENT; COMPLICATION; DISABLED PERSON; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SLEEP WAKE DISORDERS; STATISTICS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANXIETY; DEPRESSION; DISABILITY EVALUATION; DISABLED PERSONS; FATIGUE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; PSYCHIATRIC STATUS RATING SCALES; SLEEP WAKE DISORDERS; STATISTICS AS TOPIC; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84959216202     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2016.02.011     Document Type: Article

References (31)

1. Akaishi T., Nakashima I., Misu T., Fujihara K., Aoki M. Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica. J. Neuroimmunol. 2015, 283:70-73.
2. Amato M.P., Ponziani G., Rossi F., Liedl C.L., Stefanile C., Rossi L. Quality of life in Multiple sclerosis: the impact of depression, fatigue and disability. Mult. Scler. 2001, 7:340-344.
3. Auty A., Belanger C., Bouchard J.P., Brunet D.G., Duquette P., Francis G.S., Freedman M.S., Hader W.J., Marshall S.C., Maxner C.E., Metz L. Burden of illness of multiple sclerosis: part I: cost of illness. The Canadian Burden of Illness Study Group. Can. J. Neurol. Sci. 1998, 25:23-30.
4. Braley T.J., Chervin R.D. Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment. Sleep 2010, 33:1061-1067.
5. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213.
6. Chanson J.B., Zéphir H., Collongues N., Outteryck O., Blanc F., Fleury M., Vermersch P., de Seze J. Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica. Eur. J. Neurol. 2011, 18:836-841.
7. Clavelou P., Auclair C., Taithe F., Gerbaud L. Quality of life in multiple sclerosis: theoretical and practical aspects. Rev. Neurol. Paris 2009, 165:F115-F124.
8. Fisk J.D., Ritvo P.G., Ross L., Haase D.A., Marrie T.J., Schlech W.F. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin. Infect. Dis. 1994, 18(Suppl. 1):S79-S83.
9. Greim B., Engel C., Apel A., Zettl U.K. Fatigue in neuroimmunological diseases. J. Neurol. 2007, 254(Suppl. 2):II102-II106.
10. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959, 32:50-55.
11. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6:278-296.
12. Huh S.Y., Kim S.H., Hyun J.W., Joung A.R., Park M.S., Kim B.J., Kim H.J. Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder. JAMA Neurol. 2014, 71:1372-1378.
13. Kang M., Liu X., Wang X., Ye H. Reliability and validity of Chinese version of the multiple sclerosis quality of life-54 questionnaire. Chin. J. Behav. Med. Brain Sci. 2009, 10.3760/cma.j.issn.1674-6554.2009.04.037.
14. Kroencke D.C., Lynch S.G., Denney D.R. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult. Scler. 2000, 6:131-136.
15. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). J. Neurol. 1983, 33:1444.
16. Likhar N., Mothe R., Esam H., Kinra G., Shah C., Dang A. Epidemiology and current treatment of neuromyelitis optica: a systematic review. Value Health 2015, 18:A750-A751.
17. Lobentanz I.S., Asenbaum S., Vass K., Sauter C., Klösch G., Kollegger H., Kristoferitsch W., Zeitlhofer J. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol. Scand. 2004, 110:6-13.
18. Maier W., Buller R., Philipp M., Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J. Affect. Disord. 1988, 14:61-68.
19. Mathiowetz V. Test-retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis. Am. J. Occup. Ther. 2003, 57:389-395.
20. Mottram P., Wilson K., Copeland J. Validation of the Hamilton Depression Rating Scale and Montgommery and Asberg Rating Scales in terms of AGECAT depression cases. Int. J. Geriatr. Psychiatry 2000, 15:1113-1119.
21. Muto M., Mori M., Sato Y., Uzawa A., Masuda S., Uchida T., Kuwabara S. Current symptomatology in multiple sclerosis and neuromyelitis optica. Eur. J. Neurol. 2015, 22:299-304.
22. Pan J., Zhao P., Cai H., Su L., Wood K., Shi F.D., Fu Y. Hypoxemia, sleep disturbances, and depression correlated with fatigue in neuromyelitis optica spectrum disorder. CNS Neurosci. Ther. 2015, 21:599-606.
23. Pittion-Vouyovitch S., Debouverie M., Guillemin F., Vandenberghe N., Anxionnat R., Vespignani H. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J. Neurol. Sci. 2006, 243:39-45.
24. Ruta D., Garratt A., Abdalla M., Buckingham K., Russell I. The SF 36 health survey questionnaire. A valid measure of health status. BMJ 1993, 307:448-449.
25. Sherman E., Han M.H. Acute and chronic management of neuromyelitis optica spectrum disorder. Curr. Treat. Options Neurol. 2015, 17:48.
26. Song Y., Pan L., Fu Y., Sun N., Li Y.J., Cai H., Su L., Shen Y., Cui L., Shi F.D. Sleep abnormality in neuromyelitis optica spectrum disorder. Neurol. Neuroimmunol. Neuroinflamm. 2015, 2:e94.
27. Tanriverdi D., Okanli A., Sezgin S., Ekinci M. Quality of life in patients with multiple sclerosis in Turkey: relationship to depression and fatigue. J. Neurosci. Nurs. 2010, 42:267-273.
28. Vickrey B.G., Hays R.D., Harooni R., Myers L.W., Ellison G.W. A health-related quality of life measure for multiple sclerosis. Qual. Life Res. 1995, 4:187-206.
29. Waters P.J., McKeon A., Leite M.I., Rajasekharan S., Lennon V.A., Villalobos A., Palace J., Mandrekar J.N., Vincent A., Bar-Or A., Pittock S.J. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012, 78:665-671. (Discussion, 669).
30. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6:805-815.
31. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489. 10.1212/01.wnl.0000216139.44259.74.